Consistent with the above studies, our results demonstrate that the activation of JNK3 and the binding of β-arrestin2 to JNK3 are dramatically increased in MPP+-treated cells, suggesting that JNK3 plays an essential role in mediating neuronal apoptosis in PD. This evidence concerns the gene MAPK10 and Parkinson disease.